IMTX Competitors & Alternatives
Compare Immatics NV with similar stocks in the same industry
Biotechnology
IMTX
Main Stock$9.02
Tradestie Score
48
Market Cap
$1.09B
Revenue Growth
-0.6%
Analyst Upside
+98.1%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.18
|
$1.22B | - | 55 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$6.61
|
$1.18B | - | 60 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$58.04
|
$1.17B | - | 52 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$20.77
|
$1.15B | 3.3 | 49 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$17.90
|
$1.14B | - | 55 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$10.60
|
$1.14B | - | 54 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$27.33
|
$1.13B | - | 54 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$5.74
|
$1.12B | - | 49 | Compare |
|
NKTR
Nektar Therapeutics
|
$70.59
|
$1.12B | - | 63 | Compare |
More IMTX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry